
VFlex
20 mg of Q-Actin® — the dose from a sponsor-funded, 180-day, double-blind head-to-head against 2,700 mg of glucosamine-chondroitin, run with no placebo arm. Measured against each group's own starting point, the Q-Actin group's improvement was more than double. A separate twelve-week trial, placebo-controlled and publicly funded, ran the same 20 mg in gummy form in the evening — the section below sets out exactly what it found and what it didn't. For the small movements you never thought about until they got harder: buttons, jar lids, the first ten minutes of the morning. Taken at night, the timing the trials used.












